Suchergebnisse - "Patel, Vishal"

PubPharm (36)

1

Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England

enthalten in: BMC infectious diseases | 2024

von Patel, V. | Levick, B. | Boult, S. | +5

2

Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England

enthalten in: BMC infectious diseases | 2024

von Patel, V. | Levick, B. | Boult, S. | +5

3

Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London : a retrospective cohort study

enthalten in: BMJ open respiratory research | 2024

von Drysdale, M. | Galimov, E. | Yarwood, M. | +11

4

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 : Evidence from the US National COVID Cohort Collaborative (N3C)

enthalten in: Clinical drug investigation | 2024

von Bell, C. | Bobbili, P. | Desai, R. | +9

5

Systematic investigation of selected bio-molecules, potentially effective in inhibiting SARS-CoV-2/COVID-19 via in-silico analysis

enthalten in: chemRxiv.org | 2024

von Vanzara, A. | Ambasana, S. | Patel, S. | +3

6

Characteristics and outcomes of patients treated with sotrovimab to prevent progression to severe COVID-19 in Belgium

enthalten in: bioRxiv.org | 2023

von Drysdale, M. | Hautekiet, T. | Singh, M. | +8

7

Examining Public Communication About Surgical Cancer Care on Twitter

enthalten in: The Journal of surgical research | 2023

von Patel, V. | Gereta, S. | Jafri, F. | +2

8

Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant

enthalten in: Hepatology communications | 2023

von Mehta, G. | Riva, A. | Ballester, M. | +93

9

Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk patients with COVID-19 in North West London: a retrospective cohort study using the Discover dataset

enthalten in: bioRxiv.org | 2023

von Drysdale, M. | Galimov, E. | Yarwood, M. | +11

10

Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland

enthalten in: bioRxiv.org | 2023

von Drysdale, M. | Tibble, H. | Patel, V. | +6